Companies are not yet rushing to relocate production to the US, but investment and dealmaking have already slowed ...

Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...

Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...

In Hazle Twp. on the end of a road in Humboldt Industrial Park, Michaels Stores wants to make its distribution center part of ...

Demand fell 1.4 per cent from the previous month in May, the statistics office said on July 4. Read more at straitstimes.com.

ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...

Merck’s stock fell 1.77% to $80.93 while the market gained, despite rising 5.26% over the past month. The company’s upcoming ...

For the fourth consecutive year, the Curiosity Cube — a mobile science lab designed to make STEM (science, technology, ...

Merck announced that the US regulators, Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...